Media Type: News

New partnership seeks to treat cause of diabetes

September, 2023

The Broad Institute and Novo Nordisk have formed a research partnership.

Tackling Diabetes From Every Angle

September, 2021

Physicians, geneticists, chemists, and other researchers in Broad’s Diabetes Research Group are working together and taking multiple approaches to improve treatment for patients with diabetes.

 

Massive NIH–industry project opens portals to target validation

February, 2019

Five years in, the US$360 million Accelerating Medicines Partnership is yielding tools to speed up drug discovery for rheumatoid arthritis, lupus, diabetes, Alzheimer disease and Parkinson disease.

DNA analysis identifies five subtypes of type two diabetes

September, 2018

The genomic study brings us closer to precision medicine for type 2 diabetes

September, 2018

Type 2 diabetes: Five genetic ‘clusters’ may explain evolution

La Medicina Personalizada para la diabetes tipo 2, cada vez más cerca

September, 2018

Más cerca de la medicina de precisión para la diabetes tipo 2

Una nueva clasificación de la diabetes tipo 2 facilitará la medicina ‘a la carta’

September, 2018

Turning risk association to biological insight in type 2 diabetes

June, 2017

Following up on findings from genome-wide association studies, researchers identify two mechanisms by which disruptions in the gene SLC16A11 may play a role in type 2 diabetes.